Skip to main content
73°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Today 8:00 EDT
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
August 20, 2025
Tags
Eli Lilly and Co
Pharmaceuticals
US: News
From
CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
August 19, 2025
Tags
Viking Therapeutics Inc
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
August 19, 2025
Tags
Home Depot Inc
Business News
Politics
From
CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
August 18, 2025
Tags
Business News
Biotechnology
Business
From
CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
August 07, 2025
Tags
Economy
United Airlines Holdings Inc
Investment strategy
From
CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
August 07, 2025
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
August 06, 2025
Tags
Novo Nordisk A/S
Breaking News: Europe
Markets
From
CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
August 05, 2025
Tags
Social issues
Healthy Returns
Roche Holding AG
From
CNBC.com News
Hims & Hers stock falls 10% on revenue miss
August 04, 2025
Tags
Health & Science
Health care industry
Hims & Hers Health Inc
From
CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
August 01, 2025
Tags
stocks
MP Materials Corp
elf Beauty Inc
From
CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
Tags
Trade
Amgen Inc
AbbVie Inc
From
CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
July 31, 2025
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
GSK plc
Business News
Biotechnology
From
CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
July 29, 2025
Tags
Earnings
Novo Nordisk A/S
Breaking News: Europe
From
CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
July 23, 2025
Tags
Health care industry
Health & Science
Hims & Hers Health Inc
From
CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
July 23, 2025
Tags
Europe Markets
Earnings reports
Technology
From
CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
July 20, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
July 16, 2025
Tags
Novo Nordisk A/S
Regeneron Pharmaceuticals Inc
Health care industry
From
CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
July 09, 2025
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
Tags
Bristol/Myers Squibb Co
Johnson & Johnson
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
June 25, 2025
Tags
Health care industry
Health & Science
Novo Nordisk A/S
From
CNBC.com News
5 things to know before the stock market opens Tuesday
June 24, 2025
Tags
Tesla Inc
Business
Technology
From
CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
June 23, 2025
Tags
Breaking News: Business
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
June 11, 2025
Tags
Health care industry
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
May 21, 2025
Tags
Business News
Novo Nordisk A/S
Business
From
CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
May 19, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
May 16, 2025
Tags
Novo Nordisk A/S
Breaking News: Europe
Pharmaceuticals
From
CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
May 15, 2025
Tags
GSK plc
Europe Economy
Breaking News: Politics
From
CNBC.com News
Why Americans pay so much more for prescription drugs
May 14, 2025
Tags
Pharmaceuticals
LILLY DRN
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.